Cite
P3‐242: PLASMA BIOMARKER WITH HIGH ACCURACY IN PREDICTING BRAIN AMYLOID‐β BURDEN: INITIAL RESULTS ACROSS TWO INDEPENDENT LARGE COHORTS—NCGG (JAPAN) AND AIBL (AUSTRALIA)
MLA
James D. Doecke, et al. “P3‐242: PLASMA BIOMARKER WITH HIGH ACCURACY IN PREDICTING BRAIN AMYLOID‐β BURDEN: INITIAL RESULTS ACROSS TWO INDEPENDENT LARGE COHORTS—NCGG (JAPAN) AND AIBL (AUSTRALIA).” Alzheimer’s & Dementia, vol. 14, July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3c4fc062c2995fb46b4c172acab92892&authtype=sso&custid=ns315887.
APA
James D. Doecke, Katsuhiko Yanagisawa, Kengo Ito, Koichi Tanaka, Chris Fowler, Ralph N. Martins, Victor L. Villemagne, Shinichi Iwamoto, Akinori Nakamura, Yutaka Arahata, Qiao-Xin Li, Colin L. Masters, Kazunari Ishii, Takashi Kato, Naoki Kaneko, Vincent Dore, Kenji Ishii, & Christopher C. Rowe. (2018). P3‐242: PLASMA BIOMARKER WITH HIGH ACCURACY IN PREDICTING BRAIN AMYLOID‐β BURDEN: INITIAL RESULTS ACROSS TWO INDEPENDENT LARGE COHORTS—NCGG (JAPAN) AND AIBL (AUSTRALIA). Alzheimer’s & Dementia, 14.
Chicago
James D. Doecke, Katsuhiko Yanagisawa, Kengo Ito, Koichi Tanaka, Chris Fowler, Ralph N. Martins, Victor L. Villemagne, et al. 2018. “P3‐242: PLASMA BIOMARKER WITH HIGH ACCURACY IN PREDICTING BRAIN AMYLOID‐β BURDEN: INITIAL RESULTS ACROSS TWO INDEPENDENT LARGE COHORTS—NCGG (JAPAN) AND AIBL (AUSTRALIA).” Alzheimer’s & Dementia 14 (July). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3c4fc062c2995fb46b4c172acab92892&authtype=sso&custid=ns315887.